COMMUNIQUÉS West-GlobeNewswire

-
Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601
22/01/2024 -
Amarin Chairman & CEO Issue Letter to Shareholders
22/01/2024 -
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
22/01/2024 -
Kraig Biocraft Laboratories Targets Vertical Markets for its Spider Silk and Shares Planned Applications
22/01/2024 -
Novo Nordisk A/S - share repurchase programme
22/01/2024 -
Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer
22/01/2024 -
Apnimed Announces New Leadership Appointments as the Company Builds Its Commercial and Human Resource Capabilities in Support of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea
22/01/2024 -
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
22/01/2024 -
ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
22/01/2024 -
Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
22/01/2024 -
ProteinLogic and Stellenbosch University receive $1.3 million grant to develop blood test to monitor response to TB antimicrobial chemotherapy
22/01/2024 -
NMD Pharma Appoints Morten Bull as SVP, General Counsel and Head of People & Business Services
22/01/2024 -
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
22/01/2024 -
Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks
22/01/2024 -
BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer
22/01/2024 -
Oculis to Host In-Person & Virtual R&D Day in New York on February 28, 2024
22/01/2024 -
Bionomics Provides a Review of 2023 and of 2024 Plans
22/01/2024 -
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024)
22/01/2024 -
Sosei Heptares Webinar Presentation for FY2023 Financial Results
22/01/2024
Pages